Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Dendritic-Cell-Vaccine-Based Immunotherapy for Hepatocellular Carcinoma: Clinical Trials and Recent Preclinical Studies
Long‐Bin Jeng, Li‐Ying Liao, Fu‐Ying Shih, et al.
Cancers (2022) Vol. 14, Iss. 18, pp. 4380-4380
Open Access | Times Cited: 21

Showing 21 citing articles:

Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside
Yue Yin, Weibo Feng, Jie Chen, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 13
Recent progress in the immunotherapy of hepatocellular carcinoma: Non-coding RNA-based immunotherapy may improve the outcome
Fatemeh Afra, Amir Ali Mahboobipour, Amir Salehi Farid, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115104-115104
Open Access | Times Cited: 18
Frontiers and future of immunotherapy for pancreatic cancer: from molecular mechanisms to clinical application
Rui Zheng, Xiaobin Liu, Yufu Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Immunotherapy and liver transplantation for hepatocellular carcinoma: Current and future challenges
Theodoros Pettas, Sofia Lachanoudi, Filippos F. Karageorgos, et al.
World Journal of Transplantation (2025) Vol. 15, Iss. 2
Closed Access
Emerging insights into the gut microbiota as a key regulator of immunity and response to immunotherapy in hepatocellular carcinoma
Siqi Ren, Yinping Zhang, Xingyue Wang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Hypoxic tumor cell line lysate-pulsed dendritic cell vaccine exhibits better therapeutic effects on hepatocellular carcinoma
Long‐Bin Jeng, Fu‐Ying Shih, Yu‐Wen Liao, et al.
British Journal of Cancer (2025)
Closed Access
Current Trends in Surgical Management of Hepatocellular Carcinoma
Isabella Angeli-Pahim, Anastasia Chambers, Sérgio Nascimento Duarte, et al.
Cancers (2023) Vol. 15, Iss. 22, pp. 5378-5378
Open Access | Times Cited: 13
A Quartet of Cancer Stem Cell Niches in Hepatocellular Carcinoma
Neha Balaji, Samiksha Kukal, Anjali Bhat, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 79, pp. 39-51
Closed Access | Times Cited: 3
Immunotherapeutic approaches in Hepatocellular carcinoma: Building blocks of hope in near future
Neda Minaei, Roya Ramezankhani, Atena Tamimi, et al.
European Journal of Cell Biology (2022) Vol. 102, Iss. 1, pp. 151284-151284
Open Access | Times Cited: 14
Immunotherapy: Constructive Approach for Breast Cancer Treatment
Umer Anayyat, Faiza Ahad, Tobias Achu Muluh, et al.
Breast Cancer Targets and Therapy (2023) Vol. Volume 15, pp. 925-951
Open Access | Times Cited: 7
The show and tell of cross-presentation
J. Magarian Blander, Kristel Joy Yee Mon, Atimukta Jha, et al.
Advances in immunology (2023), pp. 33-114
Closed Access | Times Cited: 6
Novel Molecular Targets for Immune Surveillance of Hepatocellular Carcinoma
Pietro Guerra, Andréa Martini, Patrizia Pontisso, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3629-3629
Open Access | Times Cited: 5
Racial/Ethnic Disparities and Immunotherapeutic Advances in the Treatment of Hepatocellular Carcinoma
A García, Stephen O. Mathew
Cancers (2024) Vol. 16, Iss. 13, pp. 2446-2446
Open Access | Times Cited: 1
Research Progress on Dendritic Cells in Hepatocellular Carcinoma Immune Microenvironments
Wenya Li, G Chen, Hailin Peng, et al.
Biomolecules (2024) Vol. 14, Iss. 9, pp. 1161-1161
Open Access | Times Cited: 1
MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies
Sharmila Fagoonee, Ralf Weiskirchen
Cells (2024) Vol. 13, Iss. 23, pp. 1935-1935
Open Access | Times Cited: 1
A review of the clinical experience with CMN-001, a tumor RNA loaded dendritic cell immunotherapy for the treatment of metastatic renal cell carcinoma
Mark DeBenedette, Alicia Gamble, Marcus S. Norris, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 3
Combined bulk RNA and single-cell RNA analyses reveal TXNL4A as a new biomarker for hepatocellular carcinoma
Yifan Li, Qiaozhen Zhu, Shuchang Zhou, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Clinical Applications of Combined İmmunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review
Yeşim Eralp, Utku Ateş
(2023)
Open Access | Times Cited: 2
Clinical Applications of Combined Immunotherapy Approaches in Gastrointestinal Cancer: A Case-Based Review
Yeşim Eralp, Utku Ateş
Vaccines (2023) Vol. 11, Iss. 10, pp. 1545-1545
Open Access | Times Cited: 2
Development of a Protocol for Obtaining a Homologous Cell Product of Animal Origin Intended for Preclinical Studies of Antitumor Vaccine CaTeVac
Т. Л. Нехаева, Ido Laskov, Elena I. Fedoros, et al.
Bulletin of Experimental Biology and Medicine (2024) Vol. 176, Iss. 6, pp. 806-810
Closed Access
Yu-Ping-Feng-San improve the immunosuppression of microenvironment in hepatocellular carcinoma by promoting the maturation of DCs through the JAK2-STAT3 pathway
Fei Yao, Qin Yuan, Yichao Yan, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Antibody and Cell-Based Therapies against Virus-Induced Cancers in the Context of HIV/AIDS
Julie Joseph, Grace Sandel, Ratuja Kulkarni, et al.
Pathogens (2023) Vol. 13, Iss. 1, pp. 14-14
Open Access
Page 1

Scroll to top